{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:09:56Z","timestamp":1790194196306,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejogrb.2026.115442","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:22:18Z","timestamp":1789168938000},"page":"115442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Maternal serum placental growth factor concentration in the prediction of growth outcomes and preterm birth in early-onset fetal growth restriction: a retrospective observational study"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8409-9628","authenticated-orcid":false,"given":"Laura","family":"Pentecost","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsay","family":"Creswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Nzelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115442_b0005","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.placenta.2017.09.011","article-title":"Maternal uterine artery VEGF gene therapy for treatment of intrauterine growth restriction","volume":"59","author":"David","year":"2017","journal-title":"Placenta"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115442_b0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.reprotox.2005.04.007","article-title":"Intrauterine growth restriction\u2014etiology and consequences: what do we know about the human situation and experimental animal models?","volume":"20","author":"Ergaz","year":"2005","journal-title":"Reprod Toxicol"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115442_b0015","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstetr Gynaecol"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115442_b0020","doi-asserted-by":"crossref","first-page":"S745","DOI":"10.1016\/j.ajog.2017.11.577","article-title":"Pathophysiology of placental-derived fetal growth restriction","volume":"218","author":"Burton","year":"2018","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115442_b0025","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in PE","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Investig"},{"key":"10.1016\/j.ejogrb.2026.115442_b0030","unstructured":"National Institute for Health and Care Excellence. PLGF-based testing to help diagnose suspected preterm pre-eclampsia (Diagnostics Guidance DG49). PLGF-based testing to help diagnose suspected preterm pre-eclampsia | Guidance | NICE, 2022 [Accessed 29\/01\/2026]."},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115442_b0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of PE-related adverse outcomes with the sFlt-1 (soluble fms-like Tyrosine Kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115442_b0040","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/uog.24851","article-title":"Role of placental, fetal and maternal cardiovascular markers in predicting adverse outcome in women with suspected or confirmed pre\u2010eclampsia","volume":"59","author":"Reddy","year":"2022","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"11","key":"10.1016\/j.ejogrb.2026.115442_b0045","article-title":"Associations between soluble fms\u2010like tyrosine kinase\u20101 and placental growth factor and disease severity among women with preterm eclampsia and PE","volume":"16","author":"Hastie","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115442_b0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ajog.2026.02.030","article-title":"Pregnancy and perinatal outcomes stratified by soluble fms-like tyrosine kinase-1 and placental growth factor gestation-specific thresholds in women with suspected preeclampsia","volume":"235","author":"Creswell","year":"2026","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115442_b0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-017-1226-7","article-title":"EVERREST prospective study: a 6-year prospective study to define the clinical and biological characteristics of pregnancies affected by severe early onset fetal growth restriction","volume":"17","author":"Spencer","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"issue":"18","key":"10.1016\/j.ejogrb.2026.115442_b0060","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169199","article-title":"Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restriction","volume":"133","author":"Spencer","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejogrb.2026.115442_b0065","doi-asserted-by":"crossref","unstructured":"Lees C, Marlow N, Arabin B, Bilardo CM, TRUFFLE Group. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstetr Gynecol 2013;42(4):400-408. doi:10.1002\/uog.13190.","DOI":"10.1002\/uog.13190"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115442_h0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG practice guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstetr Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115442_h0075","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/uog.14914","article-title":"Predictive accuracy of second-trimester uterine artery Doppler indices for stillbirth: a systematic review and meta-analysis","volume":"247","author":"Allen","year":"2016","journal-title":"Ultrasound Obstetr Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115442_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.placenta.2016.03.010","article-title":"Placental growth factor as a marker of fetal growth restriction caused by placental dysfunction","volume":"42","author":"Benton","year":"2016","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115442_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.preghy.2013.01.004","article-title":"Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia","volume":"3","author":"Saffer","year":"2013","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ejogrb.2026.115442_b0085","first-page":"172","article-title":"P06.09: antenatal prediction of small for gestational age using uterine artery dopplers as part of a multiparameter test in the second trimester","volume":"54","author":"Casagrandi","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115442_b0090","unstructured":"Royal College of Obstetricians and Gynaecologists (RCOG). The Investigation and Management of the Small-for-Gestational-Age Fetus Green-top Guideline No. 31 [Internet]. 2014 Jan [cited 2026 Sept 10]. Available from: https:\/\/www.rcog.org.uk\/media\/t3lmjhnl\/gtg_31.pdf."},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115442_b0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1148\/radiology.181.1.1887021","article-title":"In utero analysis of fetal growth: a sonographic weight standard","volume":"181","author":"Hadlock","year":"1991","journal-title":"Radiology"},{"issue":"9946","key":"10.1016\/j.ejogrb.2026.115442_b0100","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(14)61490-2","article-title":"International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project","volume":"384","author":"Papageorghiou","year":"2014","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115442_b0105","doi-asserted-by":"crossref","first-page":"F577","DOI":"10.1136\/archdischild-2017-313452","article-title":"Updated birth weight centiles for England and Wales","volume":"103","author":"Norris","year":"2018","journal-title":"Arch Disease Childhood - Fetal and Neonatal Edition"},{"key":"10.1016\/j.ejogrb.2026.115442_b0110","unstructured":"World Health Organisation (WHO). WHO child growth standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. https:\/\/www.who.int\/publications\/i\/item\/924154693X, 2006. [accessed 29\/01\/26]."},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115442_b0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/pd.6047","article-title":"Development of standard definitions and grading for maternal and fetal adverse event terminology","volume":"42","author":"Spencer","year":"2021","journal-title":"Prenatal Diagnosis"},{"key":"10.1016\/j.ejogrb.2026.115442_b0120","unstructured":"Services USDOHAH. Common Terminology Criteria for Adverse Events (CTCAE) Version 6.0. 2017. Available at: https:\/\/dctd.cancer.gov\/research\/ctep-trials\/for-sites\/adverse-events\/ctcae-v6.pdf [Accessed 04\/07\/26]."},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115442_b0125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/archdischild-2019-317399","article-title":"Development of a neonatal adverse event severity scale through a Delphi consensus approach","volume":"104","author":"Salaets","year":"2019","journal-title":"Arch Dis Childhood"},{"issue":"18","key":"10.1016\/j.ejogrb.2026.115442_b0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173563","article-title":"Scaling the EVERREST of severe, early-onset fetal growth restriction","volume":"133","author":"Su","year":"2023","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.115442_b0135","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/1471-0528.17752","article-title":"Prediction of preterm birth in growth\u2010restricted and appropriate\u2010for\u2010gestational\u2010age infants using maternal PlGF and the sFlt-1\/PlGF ratio\u2014A prospective study","volume":"131","author":"Hong","year":"2024","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115442_b0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/uog.17490","article-title":"Predicting delivery of a small-for-gestational-age infant and adverse perinatal outcome in women with suspected pre-eclampsia","volume":"51","author":"Griffin","year":"2018","journal-title":"Ultrasound Obstetr Gynecol"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.115442_b0145","article-title":"Placental growth factor and uterine-artery Doppler for prediction of preeclampsia, fetal growth restriction and early preterm birth","volume":"48","author":"Figueiro-Filho","year":"2026","journal-title":"J Obstetr Gynaecol Canada"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115442_b0150","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/AOG.0000000000003694","article-title":"Placental growth factor and the risk of adverse neonatal and maternal outcomes","volume":"135","author":"Parchem","year":"2020","journal-title":"Obstetr Gynecol"},{"key":"10.1016\/j.ejogrb.2026.115442_b0155","doi-asserted-by":"crossref","unstructured":"Figueiro-Filho EA, Dietrich GM, Souza Lira AP, Ramadan E. Placental Growth Factor and Compromised Fetal Growth: Associations with Placental Ultrasound Morphology and Pathology in a Retrospective Cohort Study. Journal of Obstetrics and Gynaecology Canada [Internet]. 2026 July [cited 2026 Sept 10];48(7):103371. Available from: doi:10.1016\/j.jogc.2026.103371.","DOI":"10.1016\/j.jogc.2026.103371"},{"issue":"10183","key":"10.1016\/j.ejogrb.2026.115442_b0160","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0140-6736(18)33212-4","article-title":"Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial","volume":"393","author":"Duhig","year":"2019","journal-title":"The Lancet"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115442_b0165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase\u2013specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526005105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526005105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:52:12Z","timestamp":1790193132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526005105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":34,"alternative-id":["S0301211526005105"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115442","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal serum placental growth factor concentration in the prediction of growth outcomes and preterm birth in early-onset fetal growth restriction: a retrospective observational study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115442","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115442"}}